Clinical Roundup Insight Genetics launches test for triple negative breast cancer December 14, 2018Vol.44 No.46
Clinical Roundup Biotheranostics presents data on the Breast Cancer Index December 14, 2018Vol.44 No.46
Clinical Roundup First-line immunotherapy combination fails to improve OS in lung cancer December 14, 2018Vol.44 No.46
Clinical Roundup Amifostine delays onset of acute esophagitis for small cell lung cancer patients December 14, 2018Vol.44 No.46
Clinical Roundup Kite announces two-year data for Yescarta in patients with refractory large B-cell lymphoma December 07, 2018Vol.44 No.45
Clinical Roundup Kite announces updated data from ZUMA-3 study of KTE-X19 in adult patients with relapsed or refractory ALL December 07, 2018Vol.44 No.45
Clinical Roundup Ibrutinib + rituximab superior to standard treatment for some patients with CLL December 07, 2018Vol.44 No.45
Clinical Roundup Data from phase I/II open-label study of BCMA-directed CAR-T cell therapy lcar-b38m show tolerable safety profile, high response and MRD-negative rate in advanced r/r multiple myeloma December 07, 2018Vol.44 No.45
Clinical Roundup New long-term data on acalabrutinib in mantle cell lymphoma and CLL December 07, 2018Vol.44 No.45
Clinical Roundup Geron announces OS data from IMbark in Imetelstat-treated patients with intermediate or high-risk myelofibrosis and r/r to JAK inhibitor December 07, 2018Vol.44 No.45
